The Length of the CTLA-4 Microsatellite (AT)_N-Repeat Affects the Risk for Type 1 Diabetes: For the Swedish Childhood Diabetes Study Group

References

• Davies J L, Kawaguchi Y, Bennett S T, Copeman J B, Cordell H J, Pritchard L E, Reed P W, Gough S CL, Jenkins S C, Palmer S. M. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130–136
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Quattrocchi C C, Nistico L. Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence. Diabetes Metab. Rev. 1998; 14: 111–128
   PubMed Web of Science ®Google Scholar
• Concannon P, Gogolin E KJ, Hinds D A, Wapelhorsl B, Morrison V A, Stirling B, Mitra M, Farmer J, Williams S R, Cox N. J. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nature Genetics 1998; 19: 292–6
   PubMed Web of Science ®Google Scholar
• Schranz D, Lernmark Å. Immunology in Diabetes: An Update. Diab. Metab. Rev. 1998; 14: 3–29
   PubMed Web of Science ®Google Scholar
• Nistico L, Buzzetti R, Pritchard L E, Van der Auwera B, Gio-Vaninni C., Bosi E, Larrad M T, Rios M S, Chow C C, Cockram C. S. The CTLA-4 gene region on chromosome 2q33 is linked to, and associated with type 1 diabetes. Belgian-Diabetes Registry. Human Molecular Genetics 1996; 5: 1075–1080
   PubMed Web of Science ®Google Scholar
• Awata T, Kurihara S, Litaka M, Takei S, Inoue I, Lshii C., Negishi K, Izumida T., Yoshida Y, Hagura R. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998; 47: 128–9
   PubMed Web of Science ®Google Scholar
• Krokowski M, Bodalski J, Bratek A, Machejko P, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. 1998; 24
   Google Scholar
• Marron M P, Raffel L J, Garchon J H, Jacob C O, Serrano-Rios M, Martinez-Larrad M T, Teng W P, Park Y, Zhang Z X, Goldstein D. R. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet 1997; 6: 12751282
   Web of Science ®Google Scholar
• Todd J A, Farrall M. Panning for gold: Genome-wide scanning for linkage in type 1 diabetes. Human Molecular Genetics 1996; 5: 1443–1448
   PubMed Web of Science ®Google Scholar
• Tivol E A, Bordello F, Schweitzer A N, Lynch W P, Bluestone J, Sharpe A. H. Loss of CTLA-4 leads to massive lymphopro-liferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541–547
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Nistico L, Pozilli P, Serrano-Rios M, Larraz M, Tosi R, Giovannini C. The CTLA-4 microsatellite identifies a new region on chromosome 2 linked to IDDM. Diabetelogia 1995; 38: 105
   Web of Science ®Google Scholar
• Yanagawa T, Taniyama M, Enomoto S, Gomi Z., Maruyama H, Ban Y, Saruta T. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7: 843–846
   PubMed Web of Science ®Google Scholar
• Donner H, Seidl C, Braun J, Siegmund T, Herwig J, Seifried E, Usadel K H, Badenhoop K. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high- risk HLA DQ8 or DA2 alleles in German families. Diabetes 1998; 47: 1158–1160
   PubMed Web of Science ®Google Scholar
• Deichmann K, Heinzmann A, Bruggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem. Biophys. Res. Commun 1996; 225: 817–8
   PubMed Web of Science ®Google Scholar
• Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach J F, Caillat-Zuc-Man S. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998; 47: 125–127
   PubMed Web of Science ®Google Scholar
• Dahlquist G, Blom L, Holmgren G, Hägglöf B, Larsson Y, Sterky G, Wall S. The epidemiology of diabetes in Swedish children 0-14 years old a six-year prospective study. Diabet-ologia 1985; 28: 802–808
   PubMed Web of Science ®Google Scholar
• Östman J, Amqvist H, Blohmé G, Lithner F, Littorin B, Nyström L, Sandström A, Scherstén B, Wall S, Wibell L. Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15-34 years. Acta Med Scand 1986; 220: 437–445
   PubMedGoogle Scholar
• Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387–395
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M, Karlsson F A, Lernmark Å, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-34 years old patients in the Diabetes Incidence Study in Sweden (DISS). Diabetes 1992; 41: 1022–1027
   PubMed Web of Science ®Google Scholar
• Agresti A. Categorical Data Analysis. Inc. JWS, ed., New York 1990; 48–54
   Google Scholar
• Donner H, Rau H, Walfish P G, Braun J, Siegmund T, Finke R, Herwig J, Usadel K H, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' diease and to type 1 diabtes mellitus. J. Clin. Endocrinol. Metab 1997; 82: 143–146
   PubMed Web of Science ®Google Scholar
• Badenhoop K, Donner H, Braun J, Siegmund T, Rau H, Usadel K. H. Genetic markers in diagnosis and prediction of relapse in Graves' disease. Exp. Clin. Endocrinol. Diabetes 1996; 104: 98–100
   PubMed Web of Science ®Google Scholar
• Barbesino G, Tomer Y CE., Davies T F, Greenberg D. A. Linkage analysis of candidate genes in autoimmune thryoid disease: 1. Selected immunoregulatory genes. International Consortium for the Genetics of Autoimmune Thyroid Disease. J. Clin. Endocrinol. Metab 1998; 83: 1580–1584
   PubMed Web of Science ®Google Scholar
• Braun J, Donner H, Siegmund T, Walfish P G, Usadel K H, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998; 51: 562–566
   Google Scholar
• Huang D, Liu L, Noren K, Xia S W, Trifunovic J, Pirskanen R, Lefvert S. K. Genetic association of CTLA-4 to myasthenia gravis with thymoma. J. Neuroimmunol 1998; 88: 192–198
   PubMed Web of Science ®Google Scholar
• Seidl C, Donner H, Fischer B, Usadel K H, Seifried E, Kalt-Wasser J. P., Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998; 51: 62–66
   PubMedGoogle Scholar
• Waterman E A, Watson P F, Lazarus J H, Parkes A B, Darke C, Weetman A. P. A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis. Clin. Endorcinol 1998; 49: 251–255
   PubMed Web of Science ®Google Scholar
• Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, De Groot L. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab 1995; 80: 41–45
   PubMed Web of Science ®Google Scholar
• Drell D W, Notkins A. L. Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 132–143
   PubMed Web of Science ®Google Scholar
• Field L L, Tobias R. Unraveling complex trait: the genetics of insulin-dependent diabetes mellitus. Clin Invest Med 1997; 20: 41–47
   PubMed Web of Science ®Google Scholar